Covered recipient · General Payments record
OHARA AIVAZ
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$3,443.67
- Reported across 124 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $655.93 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $308.61 | 15 |
| Amgen Inc. | $203.17 | 4 |
| Janssen Biotech, Inc. | $76.34 | 4 |
| Lilly USA, LLC | $28.20 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.24 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.07 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189180 | CMS |
| ABBVIE INC. | $17.39 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189182 | CMS |
| ABBVIE INC. | $7.84 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189184 | CMS |
| ABBVIE INC. | $21.25 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189186 | CMS |
| ABBVIE INC. | $1.56 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189188 | CMS |
| ABBVIE INC. | $29.35 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189190 | CMS |
| ABBVIE INC. | $34.99 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189192 | CMS |
| ABBVIE INC. | $7.42 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189194 | CMS |
| ABBVIE INC. | $0.82 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189196 | CMS |
| ABBVIE INC. | $25.63 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189198 | CMS |
| ABBVIE INC. | $101.27 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189200 | CMS |
| ABBVIE INC. | $33.76 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189202 | CMS |
| ABBVIE INC. | $5.16 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189204 | CMS |
| ABBVIE INC. | $0.58 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189206 | CMS |
| ABBVIE INC. | $6.52 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189208 | CMS |
| Amgen Inc. | $32.15 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117490848 | CMS |
| Amgen Inc. | $15.69 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117490852 | CMS |
| Amgen Inc. | $34.48 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117490850 | CMS |
| Amgen Inc. | $120.85 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115413310 | CMS |
| Janssen Biotech, Inc. | $21.51 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078390964 | CMS |
| Janssen Biotech, Inc. | $25.98 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078388518 | CMS |
| Janssen Biotech, Inc. | $14.97 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078391448 | CMS |
| Janssen Biotech, Inc. | $13.88 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078388473 | CMS |
| Lilly USA, LLC | $28.20 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135249836 | CMS |
| Novartis Pharmaceuticals Corporation | $24.24 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086627061 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.37 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152188813 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.